Most Read Articles
12 Nov 2017
Active and passive smoking are associated with atopic dermatitis, a new study from Korea reveals.
Pank Jit Sin, 09 Aug 2018

Atezolizumab (Tecentriq®, Roche) a programmed death-ligand 1 (PD-L1) inhibitor, is now approved for the treatment of patients with metastatic non-small cell lung cancer who have diseases progression during or following a platinum-containing therapy.

Pearl Toh, 19 Apr 2017
Almost half of secondary school children who had been diagnosed with asthma had suboptimal asthma control, yet over half of those surveyed did not use their inhalers as prescribed, a recent study found.

Physical activity, cardiorespiratory fitness reduce anxiety, panic, depressive symptoms

27 Sep 2017
Sweating it out once a week can still keep you as fit as another who works out daily, say researchers

Physical activity and cardiorespiratory fitness seem to reduce the odds of generalized anxiety, panic and depressive symptoms, a recent cross-sectional study has shown. In contrast, muscle strengthening activities exert no effects on these symptoms.

Males in the top tertile of moderate-to-vigorous physical activity (MVPA) had significantly lower chances of having generalized anxiety, panic and depressive symptoms, determined either through the Composite International Diagnostic Interview (CIDI) or through self-assessments (adjusted odds ratio [OR], 0.68; 95 percent CI, 0.48 to 0.96; p=0.02), than those in the bottom tier.

Females in the top MVPA tertile also had lower chances of manifesting the said symptoms than those in the bottom tertile (adjusted OR, 0.54; 0.29 to 1.02; p=0.05).

Compared with participants who had low fitness, those with high cardiorespiratory fitness had significantly lower odds of self-reported or CIDI-determined symptoms of general anxiety, panic and depression (adjusted OR, 0.60; 0.39 to 0.92; p=0.02) after adjusting or age, sex, ethnicity and other potential confounders.

In contrast, meeting the muscle strengthening guideline showed no significant associations with generalized anxiety, panic and depressive symptoms even after adjusting for potential confounders such as aerobic physical activities.

Taking all three variables into consideration, a dose-dependent association between the composite variable and CIDI-determined generalized anxiety, panic and depressive symptoms was observed.

Specifically, individuals who met the guidelines of one (OR, 0.61; 0.29 to 1.31; p=0.20), two (OR, 0.46; 0.19 to 1.11; p=0.08) or three (OR, 0.29; 0.10 to 0.77; p=0.01) of the above parameters had lower odds of manifesting the symptoms compared with those who fulfilled none of the guideline values.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Nov 2017
Active and passive smoking are associated with atopic dermatitis, a new study from Korea reveals.
Pank Jit Sin, 09 Aug 2018

Atezolizumab (Tecentriq®, Roche) a programmed death-ligand 1 (PD-L1) inhibitor, is now approved for the treatment of patients with metastatic non-small cell lung cancer who have diseases progression during or following a platinum-containing therapy.

Pearl Toh, 19 Apr 2017
Almost half of secondary school children who had been diagnosed with asthma had suboptimal asthma control, yet over half of those surveyed did not use their inhalers as prescribed, a recent study found.